RISING PHARMACEUTICALS 2023-03-01 Health serious FDA
Health · FDA · Recall #FDA-D-0348-2023
Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising… Recall
Issued March 1, 2023 · RISING PHARMACEUTICALS
In March 2023, RISING PHARMACEUTICALS recalled the Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications
What you should do
- 1 Stop using Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact RISING PHARMACEUTICALS to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- RISING PHARMACEUTICALS
- Category
- Health
- Recall date
- March 1, 2023
- Units affected
- Not reported
- Sold at
- Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.
- Recall number
- FDA-D-0348-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- RISING PHARMACEUTICALS has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.